STRIDES PHARMA SCIENCE LIMITED (STAR)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 563.56 475.32 540.29 520.02 617.63 554.75 609.96 550.92 555.96 498.62 522.15 553.63
YOY Revenue Growth % 23.68% 12.32% 12.27% 34.54% 9.6% 16.71% 12.89% 5.94% -9.99% -10.12% -14.4% 0.49%
Other Income 26.38 11.65 22.34 8.69 29.63 11.83 23.55 2.43 12.12 1.76 14.09 103.24
Total Income 589.94 486.97 562.63 528.70 647.27 566.58 633.50 553.35 568.08 500.37 536.24 656.88
Total Expenses + 392.24 404.99 493.03 484.34 481.77 468.05 533.30 492.51 539.76 483.97 510.86 522.07
Cost of Materials Consumed 203.55 215.10 288.94 302.14 266.45 253.77 301.91 295.26 268.29 210.98 255.66 255.50
Employee Benefit Expense 64.53 76.70 86.25 85.66 86.60 94.87 96.76 93.80 91.86 94.04 96.49 95.14
Other Expenses 124.16 113.19 117.84 96.55 128.72 119.41 134.63 103.45 113.92 95.16 81.42 104.95
Operating Profit 171.32 70.33 47.26 35.67 135.87 86.70 76.66 58.41 16.20 14.65 11.30 31.56
OPM % 30.4% 14.8% 8.7% 6.9% 22% 15.6% 12.6% 10.6% 2.9% 2.9% 2.2% 5.7%
Profit Before Tax + 65.20 9.13 4.19 3.52 52.78 5.66 14.43 21.38 28.32 16.40 25.39 134.80
Tax Expense 2.80 1.13 2.91 0.98 -0.89 1.75 -0.88 6.44 12.20 3.06 -6.65 12.91
Tax % 4.3% 12.3% 69.4% 27.8% -1.7% 30.8% -6.1% 30.1% 43.1% 18.6% -26.2% 9.6%
Profit After Tax 62.40 8.00 1.28 2.54 53.66 3.92 15.31 14.94 16.13 13.35 32.04 121.90
EPS (Basic) 6.91 0.89 0.14 0.28 5.84 0.43 1.66 1.62 1.75 1.45 3.48 13.22

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 2,139.42 2,153.26 1,854.50 1,979.00 1,857.57 1,674.15 1,537.44
YOY Revenue Growth % -0.64% 16.11% -6.29% 6.54% 10.96% 8.89% -
Other Income 46.19 72.31 84.07 123.49 89.00 100.16 114.61
Total Income 2,185.61 2,225.56 1,938.56 2,102.49 1,946.56 1,774.31 1,652.05
Total Expenses + 2,107.50 1,864.13 1,710.51 1,736.29 1,731.47 1,424.47 1,423.35
Cost of Materials Consumed 1,048.11 1,072.63 1,020.10 935.42 1,050.10 848.34 903.77
Employee Benefit Expense 377.59 335.21 267.01 272.09 272.72 221.77 223.21
Other Expenses 415.86 456.30 423.40 528.77 408.65 354.36 296.37
Operating Profit 31.92 289.13 143.99 242.72 126.09 249.68 114.09
OPM % 1.5% 13.4% 7.8% 12.3% 6.8% 14.9% 7.4%
Profit Before Exceptional 78.11 74.99 -49.76 21.51 111.64 151.86 116.55
Exceptional Items -0.03 -5.37 -15.00 0.00 0.00 0.00 -3.52
Profit Before Tax + 78.08 69.62 -64.76 21.51 111.64 151.86 113.03
Tax Expense -2,808.13 4.13 -69.44 -158.68 33.40 40.16 2.66
Tax % -3596.3% 5.9% - -737.8% 29.9% 26.4% 2.4%
Profit After Tax 2,886.21 65.49 4.68 180.19 78.24 111.70 110.37
EPS (Basic) 313.68 7.20 0.52 20.08 8.73 12.47 12.33

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 2,885.44 3,421.93 3,493.34 0.00 0.00 0.00 0.00
Property, Plant & Equipment 606.42 507.87 555.67 0.00 0.00 0.00 0.00
Capital Work in Progress 65.74 57.71 15.79 0.00 0.00 0.00 0.00
Non-Current Investments 1,847.69 2,498.34 2,491.77 0.00 0.00 0.00 0.00
Goodwill 115.58 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 34.02 36.72 28.63 0.00 0.00 0.00 0.00
Current Assets + 2,145.50 2,415.86 2,126.40 0.00 0.00 0.00 0.00
Inventories 431.71 470.18 490.76 0.00 0.00 0.00 0.00
Trade Receivables 1,452.93 1,508.51 1,307.78 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 6.33 92.71 82.11 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 92.16 91.90 90.30 0.00 0.00 0.00 0.00
Other Equity 3,100.57 3,469.22 3,364.75 0.00 0.00 0.00 0.00
Non-Current Liabilities 208.60 281.36 367.86 0.00 0.00 0.00 0.00
Current Liabilities 1,629.61 1,995.30 1,796.83 0.00 0.00 0.00 0.00
Total Liabilities 1,838.21 2,276.66 2,164.69 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 421.48 -35.76 241.74 -282.69 0.00 0.00 0.00
Cash from Investing Activities -137.59 -61.27 -182.58 18.78 0.00 0.00 0.00
Cash from Financing Activities -370.32 107.62 10.82 250.73 0.00 0.00 0.00
Net Increase/Decrease in Cash -86.42 10.60 69.98 -13.18 0.00 0.00 0.00